What drove DOCM.SW stock movement after the report?

Share moves followed an EBITDA break-even target for 2026 and guidance updates. Key drivers were EPS of **-4.58**, cash per share **7.89**, and volume of **452005** shares as investors reassessed recovery timing.

What is Meyka AI's forecast for DOCM.SW stock?

Meyka AI's forecast model projects **CHF 2.09** monthly and **CHF 5.56** quarterly. Versus **CHF 4.01**, that implies scenario downside **-47.88%** or upside **38.65%**. Models are projections, not guarantees.

What are the main risks for DOCM.SW stock?

Primary risks are persistent negative EPS, weak free cash flow, and execution risk on margin recovery. Sector comparisons show higher valuation peers, so missed targets could pressure the share price.

Is DOCM.SW stock a value buy at current levels?

Low P/S **0.18** and P/B **0.24** suggest value, but negative profitability and FCF mean value is conditional on hitting EBITDA targets. This is a speculative, turnaround-sensitive trade.

CH Stocks

DOCM.SW DocMorris AG (SIX) 20 Mar 2026 earnings recap: guidance and next moves

ByDanny Kontos March 21, 2026

DOCM.SW stock closed at CHF 4.01 on the SIX in Switzerland as markets shut on 20 Mar 2026. DocMorris AG reported results and reiterated a 2026 target to reach EBITDA break-even. Investors will watch guidance, cash metrics and margins after the print. This earnings spotlight explains the numbers, market reaction, valuation and near-term forecast from Meyka AI